Feasibility of the use of phosphodiesterase type 5 Inhibitors in a pharmacologic prevention program for recurrent priapism

Arthur L. Burnett, Trinity J. Bivalacqua, Hunter C. Champion, Biljana Musicki

Research output: Contribution to journalArticlepeer-review

99 Scopus citations

Fingerprint

Dive into the research topics of 'Feasibility of the use of phosphodiesterase type 5 Inhibitors in a pharmacologic prevention program for recurrent priapism'. Together they form a unique fingerprint.

Medicine & Life Sciences